Skip to main content

Want a detailed portfolio tracker?

Opthea (OPT) Revenue (2007 - 2025)

Opthea (OPT) revenue from Jun 30, 2007 to Mar 31, 2025. The TTM Opthea (OPT) revenue is $140K. You can adjust inflation or export chart.

Annual Revenue

Quarterly Revenue

Opthea (OPT) Revenue CAGR table

PeriodCAGR
1 Year TTM-31.43%
5 Years TTM-19.90%
10 Years TTM-19.89%
All Time TTM+9.08%

Annual Revenue change of Opthea (OPT)

YearRevenueChange
2025$6.25K-92.18%
2024$80K-25.02%
2023$107K+18.79%
2022$90K+32.94%
2021$67K-34.80%
2020$103K+35.09%
2019$77KN/A
2018$0N/A
2017$0N/A
2016$0N/A
2015$0N/A
2014$0N/A
2013$0N/A
2012$0N/A
2011$0N/A
2010$0N/A
2009$0-100.00%
2008$9.58K-44.19%
2007$17KN/A

Comparison Opthea (OPT) five years revenue CAGR with competitors

Opthea (OPT) five years revenue CAGR is 11.41%.

TickerNamefive years Revenue CAGRUpside
BEAMBeam Therapeutics Inc484.70%+4148.02%
RYTMRhythm Pharmaceuticals Inc473.51%+4050.00%
CRMDCorMedix Inc336.16%+2846.22%
TGTXTG Therapeutics Inc278.04%+2336.84%
GERNGeron Corp257.04%+2152.77%
RVNCRevance Therapeutics Inc216.35%+1796.14%
FENCFennec Pharmaceuticals Inc202.90%+1678.31%
IBRXImmunityBio Inc200.12%+1653.89%
ASNDAscendis Pharma A/S175.66%+1439.51%
VXRTVaxart Inc174.17%+1426.46%
SNDXSyndax Pharmaceuticals Inc169.88%+1388.84%
AAPGAscentage Pharma Group International160.77%+1309.04%
OCGNOcugen Inc153.09%+1241.70%
BBIOBridgeBio Pharma Inc131.56%+1053.03%
PRTAProthena Corporation plc131.47%+1052.22%
CTXRCitius Pharmaceuticals Inc128.54%+1026.57%
TLXTelix Pharmaceuticals Ltd127.76%+1019.72%
PRQRProQR Therapeutics N.V121.71%+966.66%
BOLTBolt Biotherapeutics Inc121.10%+961.35%
PLURPluri Inc115.90%+915.80%
RPTXRepare Therapeutics Inc114.08%+899.84%
ATHEAlterity Therapeutics Ltd111.91%+880.77%
VRDNViridian Therapeutics Inc111.57%+877.82%
MRSNMersana Therapeutics Inc109.71%+861.55%
FHTXFoghorn Therapeutics Inc108.52%+851.07%
ARDXArdelyx Inc101.30%+787.79%
ARGXArgen X SE98.17%+760.36%
SEERSeer Inc - Class A94.78%+730.64%
ABUSArbutus Biopharma Corp90.98%+697.34%
GYREGyre Therapeutics Inc80.86%+608.66%
ENSCEnsysce Biosciences Inc79.79%+599.34%
TARSTarsus Pharmaceuticals Inc74.12%+549.61%
LEGNLegend Biotech Corp70.27%+515.90%
ADAGAdagene Inc61.38%+437.91%
CVACCureVac N.V.60.56%+430.72%
ADMAAdma Biologics Inc60.37%+429.08%
RXRXRecursion Pharmaceuticals Inc - Class A59.35%+420.13%
CGENCompugen Ltd57.53%+404.23%
ADAPAdaptimmune Therapeutics plc American Depositary Shares55.42%+385.71%
LCTXLineage Cell Therapeutics Inc54.06%+373.78%
CUECue Biopharma Inc53.77%+371.24%
MRKRMarker Therapeutics Inc53.28%+366.94%
IDYAIdeaya Biosciences Inc53.10%+365.34%
TRAWTraws Pharma Inc51.20%+348.77%
ALNYAlnylam Pharmaceuticals Inc49.77%+336.19%
FDMT4D Molecular Therapeutics Inc49.16%+330.83%
ZLABZai Lab Ltd49.02%+329.60%
URGNUroGen Pharma Ltd48.76%+327.36%
ARWRArrowhead Pharmaceuticals Inc47.49%+316.21%
ONCBeiGene Ltd46.08%+303.88%
ARCTArcturus Therapeutics Holdings Inc43.41%+280.43%
AUPHAurinia Pharmaceuticals Inc42.37%+271.32%
BCYCBicycle Therapeutics Plc41.82%+266.49%
XBIOXenetic Biosciences Inc41.05%+259.77%
MNKDMannkind Corp40.31%+253.28%
ZVRAZevra Therapeutics Inc39.30%+244.42%
BRTXBioRestorative Therapies Inc38.99%+241.69%
IMRNImmuron Ltd38.57%+238.06%
MGTXMeiraGTx Holdings plc37.98%+232.86%
CPRXCatalyst Pharmaceuticals Inc37.80%+231.29%
HRMYHarmony Biosciences Holdings Inc37.73%+230.68%
INSMInsmed Inc37.33%+227.20%
HALOHalozyme Therapeutics Inc35.42%+210.40%
WVEWave Life Sciences Ltd35.16%+208.17%
APLSApellis Pharmaceuticals Inc34.55%+202.80%
ARVNArvinas Inc33.48%+193.41%
MESOMesoblast Ltd32.03%+180.70%
NBTXNanobiotix31.49%+176.00%
CRSPCRISPR Therapeutics AG30.10%+163.77%
SRPTSarepta Therapeutics Inc26.94%+136.12%
ANABAnaptysBio Inc26.67%+133.78%
VRCAVerrica Pharmaceuticals Inc25.37%+122.32%
LXRXLexicon Pharmaceuticals Inc24.38%+113.66%
TVTXTravere Therapeutics Inc22.05%+93.28%
RANIRani Therapeutics Holdings Inc Class A21.08%+84.71%
FOLDAmicus Therapeutics Inc19.44%+70.39%
GLPGGalapagos NV19.11%+67.45%
ACADAcadia Pharmaceuticals Inc19.04%+66.85%
DYAIDyadic International Inc DE19.03%+66.74%
OCULOcular Therapeutix Inc18.64%+63.40%
EXELExelixis Inc18.17%+59.26%
VCELVericel Corp17.77%+55.75%
CORTCorcept Therapeutics Inc17.73%+55.38%
TNGXTango Therapeutics Inc17.63%+54.54%
RIGLRigel Pharmaceuticals17.49%+53.32%
NAGENiagen Bioscience Inc16.96%+48.61%
PTGXProtagonist Therapeutics Inc16.30%+42.82%
RAREUltragenyx Pharmaceutical Inc14.93%+30.86%
INCYIncyte Corp14.68%+28.65%
STROSutro Biopharma Inc14.67%+28.61%
MRUSMerus N.V14.54%+27.39%
PTCTPTC Therapeutics Inc13.95%+22.29%
VRTXVertex Pharmaceuticals Inc13.75%+20.53%
CELUCelularity Inc - Class A13.21%+15.76%
JAZZJazz Pharmaceuticals plc12.75%+11.71%
HRTXHeron Therapeutics Inc12.60%+10.45%
CYTKCytokinetics Inc12.56%+10.12%
BMRNBiomarin Pharmaceutical Inc11.94%+4.68%
NTRBNutriband Inc11.86%+3.98%
PHARPharming Group N.V.11.69%+2.49%
SPROSpero Therapeutics Inc11.22%-1.68%
TBPHTheravance Biopharma Inc10.63%-6.86%
ABVCABVC BioPharma Inc10.50%-7.94%
REGNRegeneron Pharmaceuticals Inc10.16%-10.97%
NRIXNurix Therapeutics Inc9.95%-12.76%
DAREDare Bioscience Inc9.62%-15.67%
MDXGMimedx Group Inc9.58%-16.04%
VALNValneva SE9.35%-18.08%
CSBRChampions Oncology Inc9.14%-19.93%
IONSIonis Pharmaceuticals Inc8.38%-26.52%
CYCNCyclerion Therapeutics Inc8.20%-28.15%
LGNDLigand Pharmaceuticals Inc - Class B8.15%-28.61%
FBIOFortress Biotech Inc8.13%-28.72%
AGENAgenus Inc7.88%-30.92%
ABEOAbeona Therapeutics Inc7.77%-31.87%
MGNXMacrogenics Inc7.76%-31.95%
PLXProtalix BioTherapeutics Inc7.76%-32.01%
TECHBio-Techne Corp7.39%-35.26%
EVGNEvogene Ltd7.27%-36.24%
CRDFCardiff Oncology Inc7.25%-36.47%
JAGXJaguar Health Inc7.22%-36.68%
CLLSCellectis6.98%-38.82%
CASICASI Pharmaceuticals Inc6.66%-41.59%
IGCIGC Pharma Inc6.63%-41.92%
ACIUAC Immune SA6.29%-44.91%
DTILPrecision Biosciences Inc6.03%-47.17%
CRBPCorbus Pharmaceuticals Holdings Inc5.98%-47.56%
KPTIKaryopharm Therapeutics Inc5.95%-47.88%
NTLAIntellia Therapeutics Inc5.11%-55.25%
IVAInventiva4.71%-58.74%
DNAGinkgo Bioworks Holdings Inc - Class A4.63%-59.45%
XOMAXOMA Royalty Corp4.58%-59.83%
INVAInnoviva Inc4.13%-63.81%
ACRSAclaris Therapeutics Inc4.08%-64.28%
IMMPImmutep Ltd3.96%-65.31%
PGENPrecigen Inc3.45%-69.75%
IMTXImmatics N.V3.26%-71.39%
VTGNVistaGen Therapeutics Inc3.10%-72.86%
XNCRXencor Inc2.91%-74.51%
RPRXRoyalty Pharma plc - Class A2.82%-75.24%
ICCCImmucell Corp2.75%-75.90%
BNTXBioNTech SE2.17%-81.00%
LSTALisata Therapeutics Inc1.86%-83.66%
CDXSCodexis Inc1.52%-86.68%
HYFTMindWalk Holdings Corp1.38%-87.87%
KYMRKymera Therapeutics Inc0.86%-92.43%
ALECAlector Inc0.42%-96.34%